This clinical trial is about a new technology, named HEMOPTIC. It enables to mesure time of blood coagulation for monitoring of patients under Vitamin K antagonist (VKA). This device was created as an alternative to blood sample, that have to be done in a medical laboratory. The main goal is to evaluate the accuracy of the International Normalized Ratio (INR) measurement of this new portable device for diagnostic in vitro, among healthy patients and patients under anti-vitamin K treatment.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
40
UniversityHospitalGrenoble
La Tronche, France
International Normalized Ratio measurement: comparison to the standard reference.
Time frame: V2
International Normalized Ratio measurement: repeatability
Time frame: V2
International Normalized Ratio measurement:reproductibility
Time frame: V2
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.